Pro-Dex, Inc.
Company & revenue
About Pro-Dex, Inc.
Who they are
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities.
Detailed revenue, brand and relationship research has not yet been completed for PDEX.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
63
Fair
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
79
Strong
Financial Strength
62
Business Quality / Moat
100
Management
100
Growth Quality
43
Risk / Durability
86
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
82
Attractive
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
78/100
Building Historical Record
Model Score 78/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
WSS currently rates the company as mixed to moderately strong.
At today’s price, the WSS valuation framework currently reads as relatively attractive.
The model outlook is currently positive.
- •Valuation scores attractively
- •Recent buyback activity is present
- •Revenue fundamentals are weak
Company-specific research
Questions worth answering for PDEX
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •What is driving PDEX's revenue decline, and does the latest company filing suggest the weakness is temporary or structural?
- •Is PDEX's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is PDEX's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •Is PDEX's valuation discount tied to a temporary concern or to a longer-term business risk?
Essential Investment Snapshot
Wall Street Score
63
Opportunity Score
82
Market Cap
$204.6M
P/E Ratio
15.7
EPS
$4.22
52-Week High
$77.00
52-Week Low
$23.47
Beta
0.06
Intrinsic Value
$162.47
Shares Outstanding
3.3M
Total Revenue
$77.5M
Total Debt
$18.1M
Dividend
No current dividend
Liquidation Value / Share
$14.36
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Extreme movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for PDEX
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on PDEX.
What the Bulls Say
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Product opportunity: Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, th.
- +Positive free cash flow may provide capacity to invest in growth.
What the Bears Say
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Instruments & Supplies industry.
Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
62
Jul 24, 2026
Change
+0.7
points
Current Score
63
Oct 1, 2026
Category Changes
PDEX increased 0.7 points because Asset improved by 11.2 points, Valuation improved by 18.9 points.
Positive Contributors
- + Asset improved by 11.2 points
- + Valuation improved by 18.9 points
Negative Contributors
- − Debt declined by 7.2 points
- − Revenue declined by 12.6 points
Projected Score
Projected Score
68
Projected Change
+4.8%
Preliminary comparable-period financial changes suggest improvement of approximately 4.8 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$64.07
Intrinsic Value
$162.47
Difference
−$98.40
-60.6% vs IV
Margin of Safety
60.6%
Related Companies
Medical - Instruments & SuppliesNews
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
Best Momentum Stocks to Buy for September 18th
New Strong Buy Stocks for September 18th
Bank of New York Mellon Corp Invests $678,000 in Pro-Dex, Inc. $PDEX
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial